Vivione Biosciences | RAPID-B Technology
Vivione Biosciences is powered by RAPID-B technology, an integrated system of hardware, software and wetware that tests bacteria in key environments.
Our mission is to revolutionize the clinical and medical fields, food and industrial safety, water safety and biodefense by utilizing one compact, universal platform for all diagnostic testing that can be used for bacteria, viruses and toxins.
Taking the place of outdated culture-based, immunology-based and molecular-based methods that take countless hours and many times, days, RAPID-B provides more accurate results for each of these fields in minutes to a few hours.
Our technology has combined flow cytometry with our own proprietary reagents to achieve a single cell detection capability in minutes. Unlike culture-based methods, the RAPID-B system does not require isolation of bacteria. It works with the background interference from complex matrices like food.
- Life Sciences
The board will pay Mays $1.037 million for the 10,000-SF property, with both sides agreeing to drop law suits. It met late Tuesday afternoon and voted to extend the offer which Mays accepted.
University of Arkansas alumnus Frank Fletcher and his wife, Judy, are providing $600,000 to establish the Frank and Judy Fletcher SAKE Fund in the Sam M. Walton College of Business.
Arkansas’ performance exceeded the national average and includes a 34 percent increase in numbers of loans, the SBA said.
Spencer Jones' ARK startup led to the launch of LineGuard Med to develop SafeBreak, a device engineered to protect IV access devices from accidental dislodgment.